The Patent Finder

Evivar Medical Pty Ltd.

Also on record
Records under this name other than patents Evivar Medical Pty Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Evivar Medical Pty Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,859,198Detection and Use of Antiviral Resistance Mutations
Lapsed on the fee record
Ended Oct 14, 2026 · High confidence
Lapsed on the fee recordEnded Oct 14, 2026High confidence
US 8,211,443Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
Lapsed on the fee record
Ended Jul 3, 2024 · USPTO record
Lapsed on the fee recordEnded Jul 3, 2024USPTO record
US 8,008,000Viral variants detection and application
Lapsed on the fee record
Ended Aug 30, 2023 · USPTO record
Lapsed on the fee recordEnded Aug 30, 2023USPTO record
US 8,211,633Viral variants with altered susceptibility to nucleoside analogs and uses thereof
Term ended
Ended no later than Feb 5, 2023 · USPTO record
Term endedEnded no later than Feb 5, 2023USPTO record
US 7,745,130Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
Lapsed on the fee record
Ended Jun 29, 2022 · USPTO record
Lapsed on the fee recordEnded Jun 29, 2022USPTO record
US 8,273,527Viral variants
Term ended
Term ended Mar 10, 2022 · USPTO record
Term endedTerm ended Mar 10, 2022USPTO record
US 7,431,933Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
Term ended
Term ended Nov 26, 2021 · USPTO record
Term endedTerm ended Nov 26, 2021USPTO record
US 8,592,143Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
Lapsed on the fee record
Ended Nov 26, 2021 · USPTO record
Lapsed on the fee recordEnded Nov 26, 2021USPTO record
US 7,931,907Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same
Term ended
Term ended Aug 3, 2021 · USPTO record
Term endedTerm ended Aug 3, 2021USPTO record
US 9,701,982Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
Lapsed on the fee record
Ended Jul 11, 2021 · USPTO record
Lapsed on the fee recordEnded Jul 11, 2021USPTO record
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited